Clanton to Head ACS Divisions
Dr. Mark Clanton, NCI deputy director for cancer care delivery systems, resigned from NCI in December to join the American Cancer Society (ACS) as their chief staff medical officer for the High Plains Division and the Hawaii Pacific Corporation. During his 2½-year tenure at NCI, Dr. Clanton provided leadership to NCI's Center to Reduce Cancer Health Disparities and Office of Science Planning and Assessment, and was involved in major conferences on tobacco control, international research organizations, and complementary and alternative medicine.
"Since he arrived at NCI, Mark has contributed in bringing his expertise to bear on expanding and enhancing NCI's research portfolio to have a greater impact on cancer care delivery," said NCI Director Dr. John E. Niederhuber. "Mark's high level of dedicated service to cancer patients and communities in need was epitomized by his volunteering to lead NCI's efforts to bring relief to displaced cancer patients and others in the wake of Hurricanes Katrina and Rita last year. He and many others from NCI, NIH, and HHS were true heroes by bringing in the resources and personnel to ensure the safety and well-being of medical personnel and patients in the area."
NCI Hosts Science Writers' Seminar on Second Cancers
On January 24, NCI's Media Relations Branch will host a Science Writers' Seminar on new cancers that arise in people whose first cancer occurred in a different site in their body - often called second cancers or multiple primaries. Four NCI scientists will discuss the incidence and prevalence of such cancers, their possible causes, and how they are treated in the clinic. Presenters include Rochelle Curtis, Dr. Crystal Mackall, Dr. Lois Travis, and Dr. Peggy Tucker.
Registration will be at 9:45 a.m. in Rooms F1/2 in the Natcher Conference Center on the NIH campus. Talks will begin at 10:00 a.m. Following an 11:00 a.m. coffee break, additional presentations will run until noon. To register for the seminar, contact the NCI Media Relations Branch at 301-496-6641 or firstname.lastname@example.org.
NCI Web Site Expands Drug Information Resources
NCI's Office of Communications (OC) has increased the drug information resources available on the NCI Web site, www.cancer.gov. Since its inception in 2005, the NCI Drug Dictionary (http://www.cancer.gov/drugdictionary) has more than doubled its number of entries from approximately 500 to more than 1,200.
OC has also developed an online collection of consumer-friendly drug information summaries. The collection, which was launched in early October 2006, compiles information from the Food and Drug Administration, the National Library of Medicine, and NCI on drug approvals, proper drug usage, drug interactions, side effects, clinical trial results, and NCI press releases and news stories. In addition, each summary contains a link to current clinical trials in which the drug is being used. The drug information summaries are available online at http://www.cancer.gov/cancertopics/druginfo/alphalist.
NCI FY 2008 Budget Proposal Available Online
NCI's annual plan and budget proposal, The Nation's Investment in Cancer Research: A Plan and Budget Proposal for Fiscal Year 2008, is now available in HTML format, providing access to information about Institute programs and the future directions of cancer research. The content is accessible through assistive devices as needed. Visitors to the site will also be able to view or print a copy of this publication from a PDF file. Printed copies can be ordered via e-mail at email@example.com, phone at 1-800-4-CANCER, fax at 301-339-7968, or online at http://plan.cancer.gov. (Click on "Order this publication.")